Many of the blood proteins that could flag neurodegeneration are so scarce that standard assays barely register them. A new UK Biobank study will test whether an ultrasensitive platform can pick them ...

Findings may offer insights into disorders associated with dysregulated forgetting, including dementia and PTSD.

The FDA has set a May 1 target action date for uniQure’s Huntington’s disease gene therapy candidate ifezuntirgene inilparvovec, after accepting the company’s Biologics License Application (BLA) under ...

Genomics launches Sentira, an Anthropic Claude-powered AI platform designed to accelerate single-cell data analysis.

Study findings reframe pulmonary hypertension as a multi-organ inflammatory disorder and point to potential diagnostic, prognostic targets.

The FDA has delayed a decision on Agios Pharmaceuticals’ supplemental New Drug Application seeking additional approval for mitapivat in sickle cell disease until next year.

Shares of gene editing therapy companies mostly surged this past week on two growth catalysts: Data readouts at the European Society of Gene and Cell Therapy’s 33rd ESGCT Annual Congress, and the ...

Single-cell atlas gives researchers a baseline for exploring how injury, aging, drugs, or other changes affect cells across ...

Parse Biosciences and Nomic Bio are partnering to create Cascade, a 100-million-cell multimodal dataset combining single-cell ...

Patient safety, expanding access to gene therapy, and progress towards an HIV vaccine were prominent themes among the early ...

TrUDI three-photon microscopy captures neural activity deep in the mouse brain at single-cell resolution without removing ...

The data showed 26 percent of neurons in the prenatal cortex had copy number variants, but this decreased to about 6 percent after birth.